The global Vulvovaginal Candidiasis Treatment Industry, currently valued at US$1,035 million in 2023, is poised for substantial expansion, with a projected Compound Annual Growth Rate (CAGR) of 4.5%. Advances in healthcare technology are driving this market towards a forecasted value of US$1,607 million by 2033. Rising VVC Prevalence and Technological Advancements Fuel Market Growth The …